Project construction content

New polypeptide raw material production workshop, polypeptide drug synthesis preparation workshop, engineering technology center, staff dormitory, and public works matching production, etc. The building area is about 11,000 square meters, and more than 200 sets of new equipment have been added.

Construction scale
The company produces 1.5 tons of polypeptide API, 400 million tablets (granules) of solid preparation, 36 million bottles of freeze-dried powder injection and small-volume injection, 5 million bottles of pre-filled injection and 5 million bottles of card type injection.

Peptide Development Vision

Peptide Development Vision

New Customed Peptide Facility(2020) Floor Area: 42,000m2 Building Area: 22,000m2
New Peptide API Facility(2021) Floor Area: 50,000m2 Building Area: 16,000m2
New Peptide Drugs R&D Center(2021-2022) Floor Area: 70,000m2 Building Area: 36,000m2

Shengnuo bio PRODUCT

Atosiban Acetate Injection Carbetocin Injection OctreotideAcetate Injection Enfuvirtide for injection
Thymus for injection is new Thymopentin for Injection Levosimendan Injection Atosiban Acetate Injection

INQUIRE

NAME:

EMAIL:

MASSAGE:


Best sales manager contact

Contacts Roleagh
Tel 86-28-88203630
Fax 86-28-88203630
Email [email protected]
QQ 2539328606
Facebook LEI LI

About Shengnuo

Chengdu Shengnuo Biotechnology Co., Ltd. has "Chengdu polypeptide drug engineering technology research center" in Chengdu, mainly engaged in polypeptide, polypeptide drug and beauty peptide research. Our zero defect has passed the FDA certification, and now it has become the first-class professional peptide drug and product development, technology transfer, technical service and peptide drug industry in the scale production and export of China's parks.